Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2005 | 03-2004 | 03-2003 | 03-2002 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 294 | 411 | 470 | 801 | 557 |
| Accounts receivable | -3 | 8 | 7 | 51 | -64 |
| Other Working Capital | -99 | 27 | -35 | 116 | 74 |
| Other Operating Activity | -2,625 | -2,574 | -3,446 | -3,920 | -1,996 |
| Operating Cash Flow | $-2,432 | $-2,128 | $-3,004 | $-2,953 | $-1,429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -119 | -63 | -393 | -1,504 | -604 |
| Investing Cash Flow | $-119 | $-63 | $-393 | $-1,504 | $-604 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 75 | 4,109 | 1,807 | 2,785 | 2,612 |
| Common Stock Repurchased | N/A | -393 | -72 | -204 | -42 |
| Other Financing Activity | -39 | 1,108 | 1,554 | -18 | 262 |
| Financing Cash Flow | $36 | $4,824 | $3,289 | $2,563 | $2,832 |
| Beginning Cash Position | 3,574 | 940 | 1,048 | 2,942 | 2,143 |
| End Cash Position | 1,059 | 3,574 | 940 | 1,048 | 2,942 |
| Net Cash Flow | $-2,515 | $2,634 | $-108 | $-1,894 | $799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,432 | -2,128 | -3,004 | -2,953 | -1,429 |
| Capital Expenditure | -165 | -63 | -393 | -1,504 | -604 |
| Free Cash Flow | -2,597 | -2,191 | -3,397 | -4,457 | -2,033 |